Specifically in HCC, LCN2 expression has been described in several in vivo and in vitro studies, where it is always higher expressed in the tissue as well as in the serum of HCC patients compared to healthy subjects [18]. This evidence concerns the gene LCN2 and hepatocellular carcinoma.